149 related articles for article (PubMed ID: 10921002)
1. [CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility].
Gao J; Ren C; Zhang Q
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):185-6. PubMed ID: 10921002
[TBL] [Abstract][Full Text] [Related]
2. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
Li WY; Lai BT; Zhan XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors.
Gomes L; Lemos MC; Paiva I; Ribeiro C; Carvalheiro M; Regateiro FJ
Acta Med Port; 2005; 18(5):339-43. PubMed ID: 16611538
[TBL] [Abstract][Full Text] [Related]
7. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
Xue K; Xu L; Chen S; Ma G; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition.
Reszka E; Wasowicz W; Rydzynski K; Szeszenia-Dabrowska N; Szymczak W
Neoplasma; 2003; 50(5):357-62. PubMed ID: 14628089
[TBL] [Abstract][Full Text] [Related]
11. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
13. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
[TBL] [Abstract][Full Text] [Related]
14. [Individual susceptibility factors in the risk of lung cancer].
Stücker I
Ann Pathol; 1997; 17 Suppl 5():23-4. PubMed ID: 9453718
[No Abstract] [Full Text] [Related]
15. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
17. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase M1 polymorphism and the risk of lung cancer.
Mohr LC; Rodgers JK; Silvestri GA
Anticancer Res; 2003; 23(3A):2111-24. PubMed ID: 12894585
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP2D6 and lung cancer risk.
Shaw GL; Falk RT; Frame JN; Weiffenbach B; Nesbitt JC; Pass HI; Caporaso NE; Moir DT; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):215-9. PubMed ID: 9521436
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
